Evidence map›Paper›PMID 28970738›Full record

ArticleInfectious diseases2017

Genetic Diversity of CD14 Promoter Gene Polymorphism (

Olusola Ojurongbe, Roland I Funwei, Tara J Snyder, Najihah Aziz, Yi Li, Catherine O Falade, Bolaji N Thomas

Abstract read
In one paragraph

Article in Infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Microorganisms · 2020
    Article
  3. SNP Diversity inGenes · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Olusola OjurongbeDepartment of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria.
Roland I FunweiDepartment of Pharmacology & Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Tara J SnyderDepartment of Biomedical Sciences, College of Health Sciences and Technology, Rochester Institute of Technology, Rochester, NY, USA.
Najihah AzizDepartment of Biomedical Sciences, College of Health Sciences and Technology, Rochester Institute of Technology, Rochester, NY, USA.
Yi LiSchool of Statistics, Shanxi University of Finance and Economics, Taiyuan, China.
Catherine O FaladeDepartment of Pharmacology & Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Bolaji N ThomasDepartment of Biomedical Sciences, College of Health Sciences and Technology, Rochester Institute of Technology, Rochester, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD14 is a multifunctional receptor expressed on many cell types and has been shown to mediate immune response resulting in the activation of an inflammatory cascade, with polymorphism of its promoter (rs2569190) found to be associated with susceptibility to several diseases. In malaria infection, the CD14 gene demonstrated a pathogenic profile in regulating experimental cerebral malaria, with reports of elevated levels of soluble CD14 in serum of patients but no definitive conclusion. We present a detailed analysis of genetic diversity of CD14 promoter gene (snp -159 C/T; rs2519190) polymorphism between a malaria-infected group and uninfected controls and its association with clinical parameters of disease. Genomic DNA samples obtained from 106

Indexed as

CD14malariaparasitemiaPlasmodium falciparumpolymorphismsseveritysub-Saharan Africa

Identifiers

PMID28970738
PMCPMC5624288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.